Literature DB >> 17595458

[Levels of uric acid in serum in patients with metabolic syndrome].

D K Virsaladze, L O Tetradze, L V Dzhavashvili, N G Esaliia, D E Tananashvili.   

Abstract

The aim of our investigation was to study the peculiarities of serum uric acid (UA) levels in patients with metabolic syndrome (MS) and without it, also correlations between UA and parameters of MS features. 41 patients (mean age - 37,8+/-13,7 years) have been investigated. MS was defined by definitions of WHO (2002), ATPIII and Society of Georgia Endocrinologists (SGE). Exclusion criterion served the gout. Levels of all parameters of MS features and serum UA have been determined. MS was diagnosed in 48,7% of cases. Study group consisted of these patients, and control group - patients without MS. Serum UA levels were significantly higher in the study group in comparison with the control (6,6+/-1,4 vs. 5,4+/-1,3 mg/dl, p=0,007; respectively). In main group the cases of hyperuricemia have been documented significantly frequently than in control (65,0% vs. 33,3%, p=0,043; respectively). Obtained results shown that UA levels significantly higher and hyperuricemia cases significantly frequent at MS, which have to be taking into account during symptomatic treatment of patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17595458

Source DB:  PubMed          Journal:  Georgian Med News        ISSN: 1512-0112


  1 in total

1.  In vitro xanthine oxidase and albumin denaturation inhibition assay of Barringtonia racemosa L. and total phenolic content analysis for potential anti-inflammatory use in gouty arthritis.

Authors:  Nurul Izzati Osman; Norrizah Jaafar Sidik; Asmah Awal; Nurul Athirah Mohamad Adam; Nur Inani Rezali
Journal:  J Intercult Ethnopharmacol       Date:  2016-08-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.